Quarterly report pursuant to Section 13 or 15(d)

Basis of presentation, summary of significant accounting policies and recent accounting pronouncements (Tables)

v3.19.2
Basis of presentation, summary of significant accounting policies and recent accounting pronouncements (Tables)
6 Months Ended
Jun. 30, 2019
Accounting Policies [Abstract]  
Schedule of Antidilutive Securities

Securities that could potentially dilute loss per share in the future were not included in the computation of diluted loss per share at June 30, 2019 and 2018 because their inclusion would be anti-dilutive are as follows:

 

    June 30,
    2019   2018
Warrants to purchase common stock     3,574,257       1,671,113  
Options to purchase common stock     12,000       150,000  
Escrow shares     200,000       200,000  
Unvested restricted stock awards     42,980       571,567  
Convertible Series B preferred shares     4,999       703,000  
Total     3,834,236       3,295,680